Gross Profit: Revenues from operations less the associated costs.
AstraZeneca PLC (AZN) had Gross Profit of $12.39B for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$15.19B |
|
$2.53B |
|
$2.80B |
|
|
Gross Profit |
$12.39B |
$11.61B |
|
$3.58B |
|
$-339.00M |
|
$3.24B |
|
$3.24B |
|
$2.54B |
|
$2.54B |
|
$2.54B |
|
$2.54B |
|
$3.58B |
|
$5.13B |
|
3.10B |
|
3.12B |
|
$0.82 |
|
$0.81 |
|
| Balance Sheet Financials | |
$29.94B |
|
$12.08B |
|
$84.52B |
|
$114.46B |
|
$34.05B |
|
$24.70B |
|
$34.43B |
|
$68.48B |
|
$45.97B |
|
$-13.44B |
|
$45.97B |
|
-- |
|
| Cash Flow Statement Financials | |
$12.23B |
|
$-5.36B |
|
$-4.26B |
|
$5.43B |
|
$8.08B |
|
$2.65B |
|
-- |
|
$-4.97B |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.88 |
|
-- |
|
-- |
|
0.35 |
|
0.67 |
|
81.56% |
|
23.59% |
|
23.59% |
|
-- |
|
21.35% |
|
16.67% |
|
$10.47B |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.42 |
|
1.00 |
|
89.77 |
|
5.51% |
|
-18.86% |
|
2.21% |
|
3.59% |
|
-- |
|
$3.35 |
|
$3.92 |
|